doi:10.48130/targetome-0026-0045

[1]

Hutchinson MR, Hill-Yardin EL. 2024. Moving from brain-organ axes to mind-body unity: convergence research by neuroscientists with multi-pronged expertise. Neuroscience 559:123−124

doi: 10.1016/j.neuroscience.2024.08.021

[2]

Shen Y, Wang J, Li Y, Kang X, Gu L. 2025. Intestinal injury and changes of the gut microbiota after ischemic stroke. Frontiers in Cellular Neuroscience 19:1557746

doi: 10.3389/fncel.2025.1557746

[3]

Yamashiro K, Tanaka R, Urabe T, Ueno Y, Yamashiro Y, et al. 2017. Gut dysbiosis is associated with metabolism and systemic inflammation in patients with ischemic stroke. PLoS One 12:e0171521

doi: 10.1371/journal.pone.0171521

[4]

Chen Z, Venkat P, Seyfried D, Chopp M, Yan T, et al. 2017. Brain–heart interaction: cardiac complications after stroke. Circulation Research 121:451−468

doi: 10.1161/CIRCRESAHA.117.311170

[5]

Liao KY, Chen CJ, Hsieh SK, Pan PH, Chen WY. 2020. Interleukin-13 ameliorates postischemic hepatic gluconeogenesis and hyperglycemia in rat model of stroke. Metabolic Brain Disease 35:1201−1210

doi: 10.1007/s11011-020-00596-1

[6]

Kim E, Yang J, Beltran CD, Cho S. 2014. Role of spleen-derived monocytes/macrophages in acute ischemic brain injury. Journal of Cerebral Blood Flow and Metabolism 34:1411−1419

doi: 10.1038/jcbfm.2014.101

[7]

Liu Q, Jin WN, Liu Y, Shi K, Sun H, et al. 2017. Brain ischemia suppresses immunity in the periphery and brain via different neurogenic innervations. Immunity 46:474−487

doi: 10.1016/j.immuni.2017.02.015

[8]

Bai W, Li W, Ning YL, Li P, Zhao Y, et al. 2018. Blood glutamate levels are closely related to acute lung injury and prognosis after stroke. Frontiers in Neurology 8:755

doi: 10.3389/fneur.2017.00755

[9]

Chen X, Yang DX, Zhao H, Zhang HF, Hong P. 2024. Stroke-induced renal dysfunction: underlying mechanisms and challenges of the brain-kidney axis. CNS Neuroscience & Therapeutics 30:e70114

doi: 10.1111/cns.70114

[10]

Guo H, Tang X, He X, Weng Y, Zhang Q, et al. 2025. A comprehensive review of the role of the microbiota-gut-brain axis via neuroinflammation: advances and therapeutic implications for ischemic stroke. Biomolecules 15:920

doi: 10.3390/biom15070920

[11]

Udit S, Blake K, Chiu IM. 2022. Somatosensory and autonomic neuronal regulation of the immune response. Nature Reviews Neuroscience 23:157−171

doi: 10.1038/s41583-021-00555-4

[12]

Devanney NA, Stewart AN, Gensel JC. 2020. Microglia and macrophage metabolism in CNS injury and disease: the role of immunometabolism in neurodegeneration and neurotrauma. Experimental Neurology 329:113310

doi: 10.1016/j.expneurol.2020.113310

[13]

Stone TW, Clanchy FIL, Huang YS, Chiang NY, Darlington LG, et al. 2022. An integrated cytokine and kynurenine network as the basis of neuroimmune communication. Frontiers in Neuroscience 16:1002004

doi: 10.3389/fnins.2022.1002004

[14]

Tian DC, Shi K, Zhu Z, Yao J, Yang X, et al. 2018. Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow. Annals of Neurology 84:717−728

doi: 10.1002/ana.25352

[15]

Emsley HC, Smith CJ, Georgiou RF, Vail A, Hopkins SJ, et al. 2005. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. Journal of Neurology, Neurosurgery, and Psychiatry 76:1366−1372

doi: 10.1136/jnnp.2004.054882

[16]

Li N, Wang X, Sun C, Wu X, Lu M, et al. 2019. Change of intestinal microbiota in cerebral ischemic stroke patients. BMC Microbiology 19:191

doi: 10.1186/s12866-019-1552-1

[17]

Prame Kumar K, McKay LD, Nguyen H, Kaur J, Wilson JL, et al. 2025. Sympathetic-mediated intestinal cell death contributes to gut barrier impairment after stroke. Translational Stroke Research 16:280−298

doi: 10.1007/s12975-023-01211-y

[18]

Tuz AA, Hasenberg A, Hermann DM, Gunzer M, Singh V. 2022. Ischemic stroke and concomitant gastrointestinal complications - a fatal combination for patient recovery. Frontiers in Immunology 13:1037330

doi: 10.3389/fimmu.2022.1037330

[19]

Long-Smith C, O'Riordan KJ, Clarke G, Stanton C, Dinan TG, et al. 2020. Microbiota-gut-brain axis: new therapeutic opportunities. Annual Review of Pharmacology and Toxicology 60:477−502

doi: 10.1146/annurev-pharmtox-010919-023628

[20]

Dong TS, Mayer E. 2024. Advances in brain-gut-microbiome interactions: a comprehensive update on signaling mechanisms, disorders, and therapeutic implications. Cellular and Molecular Gastroenterology and Hepatology 18:1−13

doi: 10.1016/j.jcmgh.2024.01.024

[21]

Chen X, Gu J, Zhang X. 2024. Brain-heart axis and the inflammatory response: connecting stroke and cardiac dysfunction. Cardiology 149:369−382

doi: 10.1159/000538409

[22]

Chen G, Ding P, Yang L, Liu X, Yu D, et al. 2024. Left ventricular ejection fraction < 60 % is associated with short-term functional disability in patients of acute ischemic stroke. Heliyon 10:e29352

doi: 10.1016/j.heliyon.2024.e29352

[23]

Yperzeele L, van Hooff RJ, Nagels G, De Smedt A, De Keyser J, et al. 2015. Heart rate variability and baroreceptor sensitivity in acute stroke: a systematic review. International Journal of Stroke 10:796−800

doi: 10.1111/ijs.12573

[24]

Hermanns N, Wroblewski V, Bascuñana P, Wolf B, Polyak A, et al. 2022. Molecular imaging of the brain-heart axis provides insights into cardiac dysfunction after cerebral ischemia. Basic Research in Cardiology 117:52

doi: 10.1007/s00395-022-00961-4

[25]

Veltkamp R, Uhlmann S, Marinescu M, Sticht C, Finke D, et al. 2019. Experimental ischaemic stroke induces transient cardiac atrophy and dysfunction. Journal of Cachexia, Sarcopenia and Muscle 10:54−62

doi: 10.1002/jcsm.12335

[26]

Jia S, Xia Q, Zhang B, Wang L. 2015. Involvement of the paraventricular nucleus in the occurrence of arrhythmias in middle cerebral artery occlusion rats. Journal of Stroke and Cerebrovascular Diseases 24:844−851

doi: 10.1016/j.jstrokecerebrovasdis.2014.11.025

[27]

Ally A, Nauli SM, Maher TJ. 2005. Molecular changes in nNOS protein expression within the ventrolateral medulla following transient focal ischemia affect cardiovascular functions. Brain Research 1055:73−82

doi: 10.1016/j.brainres.2005.06.087

[28]

Wang Y, Xiong X, Xie B, Liu J, Yang M, et al. 2019. A brain-stellate ganglion-atrium network regulates atrial fibrillation vulnerability through macrophages in acute stroke. Life Sciences 237:116949

doi: 10.1016/j.lfs.2019.116949

[29]

Ouyang M, Muñoz-Venturelli P, Billot L, Wang X, Song L, et al. 2021. Low blood pressure and adverse outcomes in acute stroke: HeadPoST study explanations. Journal of Hypertension 39:273−279

doi: 10.1097/HJH.0000000000002649

[30]

Verschoof MA, Groot AE, Vermeij JD, Westendorp WF, van den Berg SA, et al. 2020. Association between low blood pressure and clinical outcomes in patients with acute ischemic stroke. Stroke 51:338−341

doi: 10.1161/STROKEAHA.119.027336

[31]

Matsuzono K, Fujimoto S, Aoki J, Ozawa T, Kimura K. 2023. Tachycardia changes increase neurological deterioration in patients with acute non-cardioembolic stroke: an ADS post-hoc analysis. Journal of Atherosclerosis and Thrombosis 30:66−73

doi: 10.5551/jat.63409

[32]

Castillo J, Leira R, García MM, Serena J, Blanco M, et al. 2004. Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 35:520−527

doi: 10.1161/01.STR.0000109769.22917.B0

[33]

Teratani T, Mikami Y, Nakamoto N, Suzuki T, Harada Y, et al. 2020. The liver-brain-gut neural arc maintains the T_reg cell niche in the gut. Nature 585:591−596

doi: 10.1038/s41586-020-2425-3

[34]

Urabe T, Watada H, Okuma Y, Tanaka R, Ueno Y, et al. 2009. Prevalence of abnormal glucose metabolism and insulin resistance among subtypes of ischemic stroke in japanese patients. Stroke 40:1289−1295

doi: 10.1161/STROKEAHA.108.522557

[35]

Wang YY, Chen CJ, Lin SY, Chuang YH, Sheu WH, et al. 2013. Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent cerebral ischemia. Molecular and Cellular Endocrinology 367:50−56

doi: 10.1016/j.mce.2012.12.016

[36]

Alexander KS, Zakai NA, Lidofsky SD, Callas PW, Judd SE, et al. 2018. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The reasons for geographic and racial differences in stroke cohort. PLoS One 13(3):e0194153

doi: 10.1371/journal.pone.0194153

[37]

Seifert HA, Hall AA, Chapman CB, Collier LA, Willing AE, et al. 2012. A transient decrease in spleen size following stroke corresponds to splenocyte release into systemic circulation. Journal of Neuroimmune Pharmacology 7(4):1017−1024

doi: 10.1007/s11481-012-9406-8

[38]

Li C, Chen W, Lin F, Li W, Wang P, et al. 2023. Functional two-way crosstalk between brain and lung: the brain-lung axis. Cellular and Molecular Neurobiology 43:991−1003

doi: 10.1007/s10571-022-01238-z

[39]

Somogyi, P, Tóth, I, Ballók, B, Hammad, Z, Hussein RA, et al. 2024. Pulmonary consequences of experimentally induced stroke: differences between global and focal cerebral ischemia. Frontiers in Physiology 15:1511638

doi: 10.3389/fphys.2024.1511638

[40]

Li X, Deng J, Long Y, Ma Y, Wu Y, et al. 2024. Focus on brain-lung crosstalk: preventing or treating the pathological vicious circle between the brain and the lung. Neurochemistry International 178:105768

doi: 10.1016/j.neuint.2024.105768

[41]

Yan Q, Liu M, Xie Y, Lin Y, Fu P, et al. 2024. Kidney-brain axis in the pathogenesis of cognitive impairment. Neurobiology of Disease 200:106626

doi: 10.1016/j.nbd.2024.106626

[42]

Tollitt J, Odudu A, Flanagan E, Chinnadurai R, Smith C, et al. 2019. Impact of prior stroke on major clinical outcome in chronic kidney disease: the Salford kidney cohort study. BMC Nephrology 20:432

doi: 10.1186/s12882-019-1614-5

[43]

Nakuluri K, Nishad R, Mukhi D, Kumar S, Nakka VP, et al. 2019. Cerebral ischemia induces TRPC6 via HIF1α/ZEB2 axis in the glomerular podocytes and contributes to proteinuria. Scientific Reports 9:17897

doi: 10.1038/s41598-019-52872-5

[44]

Zhao Q, Yan T, Chopp M, Venkat P, Chen J. 2020. Brain-kidney interaction: renal dysfunction following ischemic stroke. Journal of Cerebral Blood Flow and Metabolism 40:246−262

doi: 10.1177/0271678X19890931

[45]

Qureshi AI, Aslam H, Zafar W, Huang W, Lobanova I, et al. 2020. Acute kidney injury in acute ischemic stroke patients in clinical trials. Critical Care Medicine 48:1334−1339

doi: 10.1097/CCM.0000000000004464

[46]

Xu K, Gao X, Xia G, Chen M, Zeng N, et al. 2021. Rapid gut dysbiosis induced by stroke exacerbates brain infarction in turn. Gut 8:1486−1494

doi: 10.1136/gutjnl-2020-323263

[47]

Chen Y, Liang J, Ouyang F, Chen X, Lu T, et al. 2019. Persistence of gut microbiota dysbiosis and chronic systemic inflammation after cerebral infarction in cynomolgus monkeys. Frontiers in Neurology 10:661

doi: 10.3389/fneur.2019.00661

[48]

Shen J, Guo H, Liu S, Jin W, Zhang ZW, et al. 2023. Aberrant branched-chain amino acid accumulation along the microbiota-gut-brain axis: crucial targets affecting the occurrence and treatment of ischaemic stroke. British Journal of Pharmacology 180:347−368

doi: 10.1111/bph.15965

[49]

Kurita N, Yamashiro K, Kuroki T, Tanaka R, Urabe T, et al. 2020. Metabolic endotoxemia promotes neuroinflammation after focal cerebral ischemia. Journal of Cerebral Blood Flow and Metabolism 40:2505−2520

doi: 10.1177/0271678X19899577

[50]

Fitzpatrick Z, Frazer G, Ferro A, Clare S, Bouladoux N, et al. 2020. Gut-educated IgA plasma cells defend the meningeal venous sinuses. Nature 587(7834):472−476

doi: 10.1038/s41586-020-2886-4

[51]

Singh V, Roth S, Llovera G, Sadler R, Garzetti D, et al. 2016. Microbiota dysbiosis controls the neuroinflammatory response after stroke. The Journal of Neuroscience 36(28):7428−7440

doi: 10.1523/JNEUROSCI.1114-16.2016

[52]

Blasco MP, Chauhan A, Honarpisheh P, Ahnstedt H, d'Aigle J, et al. 2020. Age-dependent involvement of gut mast cells and histamine in post-stroke inflammation. Journal of Neuroinflammation 17:160

doi: 10.1186/s12974-020-01833-1

[53]

Dang Y, Zhang X, Zheng Y, Yu B, Pan D, et al. 2021. Distinctive gut microbiota alteration is associated with poststroke functional recovery: results from a prospective cohort study. Neural Plasticity 2021:1469339

doi: 10.1155/2021/1469339

[54]

Li Q, Guo Y, Yu X, Liu W, Zhou L. 2020. Protective mechanism of rhubarb anthraquinone glycosides in rats with cerebral ischaemia-reperfusion injury: interactions between medicine and intestinal flora. Chinese Medicine 15:60

doi: 10.1186/s13020-020-00341-x

[55]

Yin J, Liao SX, He Y, Wang S, Xia GH, et al. 2015. Dysbiosis of gut microbiota with reduced trimethylamine-N-oxide level in patients with large-artery atherosclerotic stroke or transient ischemic attack. Journal of the American Heart Association 4:e002699

doi: 10.1161/JAHA.115.002699

[56]

Lee J, Peesh P, Quaicoe V, Tan C, Banerjee A, et al. 2023. Estradiol mediates colonic epithelial protection in aged mice after stroke and is associated with shifts in the gut microbiome. Gut Microbes 15:2271629

doi: 10.1080/19490976.2023.2271629

[57]

Díaz-Marugan L, Gallizioli M, Márquez-Kisinousky L, Arboleya S, Mastrangelo A, et al. 2023. Poststroke lung infection by opportunistic commensal bacteria is not mediated by their expansion in the gut microbiota. Stroke 54:1875−1887

doi: 10.1161/STROKEAHA.123.042755

[58]

Zheng Q, Chen Y, Zhai Y, Meng L, Liu H, et al. 2022. Gut dysbiosis is associated with the severity of cryptogenic stroke and enhanced systemic inflammatory response. Frontiers in Immunology 13:836820

doi: 10.3389/fimmu.2022.836820

[59]

Huang D, Yang Y, Song W, Jiang C, Zhang Y, et al. 2023. Untargeted metabonomic analysis of a cerebral stroke model in rats: a study based on UPLC-MS/MS. Frontiers in Neuroscience 17:1084813

doi: 10.3389/fnins.2023.1084813

[60]

Park SY, Lee SP, Kim D, Kim WJ. 2023. Gut dysbiosis: a new avenue for stroke prevention and therapeutics. Biomedicines 11:2352

doi: 10.3390/biomedicines11092352

[61]

Park MJ, Pilla R, Panta A, Pandey S, Sarawichitr B, et al. 2020. Reproductive senescence and ischemic stroke remodel the gut microbiome and modulate the effects of estrogen treatment in female rats. Translational Stroke Research 11:812−830

doi: 10.1007/s12975-019-00760-5

[62]

Chelluboina B, Kieft K, Breister A, Anantharaman K, Vemuganti R. 2022. Gut virome dysbiosis following focal cerebral ischemia in mice. Journal of Cerebral Blood Flow & Metabolism 42:1597−1602

doi: 10.1177/0271678X221107702

[63]

Tan C, Wu Q, Wang H, Gao X, Xu R, et al. 2021. Dysbiosis of gut microbiota and short-chain fatty acids in acute ischemic stroke and the subsequent risk for poor functional outcomes. JPEN Journal of Parenteral and Enteral Nutrition 45:518−529

doi: 10.1002/jpen.1861

[64]

Guan Y, Liu T, Xu F, Xie S, Gu W, et al. 2023. Integration of 16S rRNA gene sequencing and LC/MS-based metabolomic analysis of early biomarkers of acute ischaemic stroke in Tibetan miniature pigs. Journal of Microbiological Methods 215:106846

doi: 10.1016/j.mimet.2023.106846

[65]

Zhu W, Romano KA, Li L, Buffa JA, Sangwan N, et al. 2021. Gut microbes impact stroke severity via the trimethylamine N-oxide pathway. Cell Host & Microbe 29:1199−1208.e5

doi: 10.1016/j.chom.2021.05.002

[66]

Zhao M, Guan L, Wang Y. 2020. The association of autonomic nervous system function with ischemic stroke, and treatment strategies. Frontiers in Neurology 10:1411

doi: 10.3389/fneur.2019.01411

[67]

Tan Q, Ruan Y, Wu S, Jiang Y, Fu R, et al. 2024. Vagus nerve stimulation (VNS) inhibits cardiac mast cells activation and improves myocardial atrophy after ischemic stroke. International Immunopharmacology 139:112714

doi: 10.1016/j.intimp.2024.112714

[68]

Wang Y, He S, Xiong X, Liu J, Xie B, et al. 2021. Left stellate ganglion ablation inhibits ventricular arrhythmias through macrophage regulation in canines with acute ischemic stroke. International Journal of Medical Sciences 18:891−901

doi: 10.7150/ijms.50976

[69]

Chen J, Gong J, Chen H, Li X, Wang L, et al. 2021. Ischemic stroke induces cardiac dysfunction and alters transcriptome profile in mice. BMC Genomics 22:641

doi: 10.1186/s12864-021-07938-y

[70]

Zheng J, Ma Y, Guo X, Wu J. 2023. Immunological characterization of stroke-heart syndrome and identification of inflammatory therapeutic targets. Frontiers in Immunology 14:1227104

doi: 10.3389/fimmu.2023.1227104

[71]

Keasey MP, Lovins C, Jia C, Hagg T. 2022. Liver vitronectin release into the bloodstream increases due to reduced vagal muscarinic signaling after cerebral stroke in female mice. Physiological Reports 10:e15301

doi: 10.14814/phy2.15301

[72]

Yan M, Man S, Sun B, Ma L, Guo L, et al. 2023. Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduction and Targeted Therapy 8:443

doi: 10.1038/s41392-023-01673-4

[73]

Cheon SY, Song J. 2021. The association between hepatic encephalopathy and diabetic encephalopathy: the brain-liver axis. International Journal of Molecular Sciences 22:463

doi: 10.3390/ijms22010463

[74]

Li D, Lian L, Huang L, Gamdzyk M, Huang Y, et al. 2024. Delayed recanalization reduced neuronal apoptosis and neurological deficits by enhancing liver-derived trefoil factor 3-mediated neuroprotection via LINGO2/EGFR/Src signaling pathway after middle cerebral artery occlusion in rats. Experimental Neurology 371:114607

doi: 10.1016/j.expneurol.2023.114607

[75]

Sá-Nakanishi AB, de Oliveira MC, O Pateis V, P Silva LA, Pereira-Maróstica HV, et al. 2020. Glycemic homeostasis and hepatic metabolism are modified in rats with global cerebral ischemia. Biochimica et Biophysica Acta Molecular Basis of Disease 1866:165934

doi: 10.1016/j.bbadis.2020.165934

[76]

Kohm AP, Sanders VM. 2001. Norepinephrine and β 2-adrenergic receptor stimulation regulate CD4⁺ T and B lymphocyte function in vitro and in vivo. Pharmacological Reviews 53:487−525

doi: 10.1016/S0031-6997(24)01510-2

[77]

Mignini F, Streccioni V, Amenta F. 2003. Autonomic innervation of immune organs and neuroimmune modulation. Autonomic & Autacoid Pharmacology 23:1−25

doi: 10.1046/j.1474-8673.2003.00280.x

[78]

Bassi GS, Kanashiro A, Coimbra NC, Terrando N, Maixner W, et al. 2020. Anatomical and clinical implications of vagal modulation of the spleen. Neuroscience and Biobehavioral Reviews 112:363−373

doi: 10.1016/j.neubiorev.2020.02.011

[79]

Liu ZJ, Chen C, Li FW, Shen JM, Yang YY, et al. 2015. Splenic responses in ischemic stroke: new insights into stroke pathology. CNS Neuroscience & Therapeutics 21:320−326

doi: 10.1111/cns.12361

[80]

Jin R, Zhong W, Liu S, Li G. 2019. CD147 as a key mediator of the spleen inflammatory response in mice after focal cerebral ischemia. Journal of Neuroinflammation 16:198

doi: 10.1186/s12974-019-1609-y

[81]

Ma Y, Li Y, Jiang L, Wang L, Jiang Z, et al. 2016. Macrophage depletion reduced brain injury following middle cerebral artery occlusion in mice. Journal of Neuroinflammation 13:38

doi: 10.1186/s12974-016-0504-z

[82]

Wang H, Chang M, Tang L, Xu J, Tang S, et al. 2026. Spleen-derived immune cells potentiate cerebral ischemia-reperfusion injury through brain-spleen communication. European Journal of Pharmacology 1013:178509

doi: 10.1016/j.ejphar.2025.178509

[83]

Chiu NL, Kaiser B, Nguyen YV, Welbourne S, Lall C, et al. 2016. The volume of the spleen and its correlates after acute stroke. Journal of Stroke and Cerebrovascular Diseases 25:2958−2961

doi: 10.1016/j.jstrokecerebrovasdis.2016.08.012

[84]

Zhang B, Yin X, Lang Y, Han X, Shao J., et al. 2021. Role of cellular prion protein in splenic CD4⁺ T cell differentiation in cerebral ischaemic/reperfusion. Annals of Clinical and Translational Neurology 8:2040−2051

doi: 10.1002/acn3.51453

[85]

Dotson AL, Chen Y, Zhu W, Libal N, Alkayed NJ, et al. 2016. Partial MHC constructs treat thromboembolic ischemic stroke characterized by early immune expansion. Translational Stroke Research 7:70−78

doi: 10.1007/s12975-015-0436-4

[86]

Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, et al. 2006. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. Journal of Immunology 176:6523−6531

doi: 10.4049/jimmunol.176.11.6523

[87]

Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, et al. 2009. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nature Medicine 15:192−199

doi: 10.1038/nm.1927

[88]

Li P, Gan Y, Sun BL, Zhang F, Lu B, et al. 2013. Adoptive regulatory T-cell therapy protects against cerebral ischemia. Annals of Neurology 74:458−471

doi: 10.1002/ana.23815

[89]

Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, et al. 2011. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. The Journal of Neuroscience 31:8556−8563

doi: 10.1523/JNEUROSCI.1623-11.2011

[90]

Qiao H, Xu Q, Xu Y, Zhao Y, He N, et al. 2023. Molecular chaperones in stroke-induced immunosuppression. Neural Regeneration Research 18:2638−2644

doi: 10.4103/1673-5374.373678

[91]

Planas AM, Gómez-Choco M, Urra X, Gorina R, Caballero M, et al. 2012. Brain-derived antigens in lymphoid tissue of patients with acute stroke. Journal of Immunology 188:2156−2163

doi: 10.4049/jimmunol.1102289

[92]

Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, et al. 2006. Experimental stroke induces massive, rapid activation of the peripheral immune system. Journal of Cerebral Blood Flow and Metabolism 26:654−665

doi: 10.1038/sj.jcbfm.9600217

[93]

Dimitrijevic OB, Stamatovic SM, Keep RF, Andjelkovic AV. 2007. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38:1345−1353

doi: 10.1161/01.STR.0000259709.16654.8f

[94]

Zhang Y, Gao Z, Wang D, Zhang T, Sun B, et al. 2014. Accumulation of natural killer cells in ischemic brain tissues and the chemotactic effect of IP-10. Journal of Neuroinflammation 11:79

doi: 10.1186/1742-2094-11-79

[95]

Zhu X, Song Z, Zhang S, Nanda A, Li G. 2014. CD147: a novel modulator of inflammatory and immune disorders. Current Medicinal Chemistry 21:2138−2145

doi: 10.2174/0929867321666131227163352

[96]

Jiang X, Andjelkovic AV, Zhu L, Yang T, Bennett MVL, et al. 2018. Blood-brain barrier dysfunction and recovery after ischemic stroke. Progress in Neurobiology 163−164:144−171

doi: 10.1016/j.pneurobio.2017.10.001

[97]

Justicia C, Panés J, Solé S, Cervera Á, Deulofeu R, et al. 2003. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. Journal of Cerebral Blood Flow & Metabolism 23:1430−1440

doi: 10.1097/01.WCB.0000090680.07515.C8

[98]

Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, et al. 2004. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke 35:1659−1664

doi: 10.1161/01.STR.0000130592.71028.92

[99]

Jickling GC, Liu D, Ander BP, Stamova B, Zhan X, et al. 2015. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. Journal of Cerebral Blood Flow and Metabolism 35:888−901

doi: 10.1038/jcbfm.2015.45

[100]

Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, et al. 2010. Extracellular DNA traps promote thrombosis. Proceedings of the National Academy of Sciences of the United States of America 107:15880−15885

doi: 10.1073/pnas.1005743107

[101]

Han D, Liu H, Gao Y, Feng J. 2021. Targeting brain-spleen crosstalk after stroke: new insights into stroke pathology and treatment. Current Neuropharmacology 19:1590−1605

doi: 10.2174/1570159x19666210316092225

[102]

Prass K, Braun JS, Dirnagl U, Meisel C, Meisel A. 2006. Stroke propagates bacterial aspiration to pneumonia in a model of cerebral ischemia. Stroke 37:2607−2612

doi: 10.1161/01.STR.0000240409.68739.2b

[103]

Naseh M, Dehghanian A, Ketabchi F. 2020. Vagotomy improves hypoxic pulmonary vasoconstriction in rats subjected to brain ischemia-reperfusion injury. Iranian Journal of Medical Sciences 45:250−258

doi: 10.30476/IJMS.2019.45789

[104]

Engel O, Akyüz L, da Costa Goncalves AC, Winek K, Dames C, et al. 2015. Cholinergic pathway suppresses pulmonary innate immunity facilitating pneumonia after stroke. Stroke 46:3232−3240

doi: 10.1161/STROKEAHA.115.008989

[105]

Schulte-Herbrüggen O, Quarcoo D, Brzoska T, Klehmet J, Meisel A, et al. 2008. Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1. Experimental Neurology 210:731−739

doi: 10.1016/j.expneurol.2008.01.006

[106]

Jagdmann S, Berchtold D, Gutbier B, Witzenrath M, Meisel A, et al. 2021. Efficacy and safety of intratracheal IIFN-γ treatment to reverse stroke-induced susceptibility to pulmonary bacterial infections. Journal of Neuroimmunology 355:577568

doi: 10.1016/j.jneuroim.2021.577568

[107]

Xu Q, Ye Y, Wang Z, Zhu H, Li Y, et al. 2022. NLRP3 knockout protects against lung injury induced by cerebral ischemia–reperfusion. Oxidative Medicine and Cellular Longevity 2022:6260102

doi: 10.1155/2022/6260102

[108]

McCulloch L, Smith CJ, McColl BW. 2017. Adrenergic-mediated loss of splenic marginal zone B cells contributes to infection susceptibility after stroke. Nature Communications 8:15051

doi: 10.1038/ncomms15051

[109]

Shim R, Wen SW, Wanrooy BJ, Rank M, Thirugnanachandran T, et al. 2020. Stroke severity, and not cerebral infarct location, increases the risk of infection. Translational Stroke Research 11:387−401

doi: 10.1007/s12975-019-00738-3

[110]

Xu FF, Zhang ZB, Wang YY, Wang TH. 2018. Brain-derived glia maturation factor β participates in lung injury induced by acute cerebral ischemia by increasing ROS in endothelial cells. Neuroscience Bulletin 34:1077−1090

doi: 10.1007/s12264-018-0283-x

[111]

Wen MD, Jiang Y, Huang J, Al-Hawwas M, Dan QQ, et al. 2019. A novel role of VEGFC in cerebral ischemia with lung injury. Frontiers in Neuroscience 13:479

doi: 10.3389/fnins.2019.00479

[112]

Hu J, Guo J, Wu C, He X, Jing J, et al. 2025. Annexin A5 derived from lung alleviates brain damage after ischemic stroke. Brain Research 1846:149303

doi: 10.1016/j.brainres.2024.149303

[113]

Chen J, Yan Y, Yuan F, Cao J, Li S, et al. 2019. Brain grey matter volume reduction and anxiety-like behavior in lipopolysaccharide-induced chronic pulmonary inflammation rats: a structural MRI study with histological validation. Brain, Behavior, and Immunity 76:182−197

doi: 10.1016/j.bbi.2018.11.020

[114]

Bohmwald K, Soto JA, Andrade-Parra C, Fernández-Fierro A, Espinoza JA, et al. 2021. Lung pathology due to hRSV infection impairs blood-brain barrier permeability enabling astrocyte infection and a long-lasting inflammation in the CNS. Brain, Behavior, and Immunity 91:159−171

doi: 10.1016/j.bbi.2020.09.021

[115]

Dai M, Yang J, Wang Z, Xue F, Wang Y, et al. 2024. Aquaporins alteration revealed kidney damages in cerebral ischemia/reperfusion rats. Heliyon 10:e31532

doi: 10.1016/j.heliyon.2024.e31532

[116]

Fujii T, Kurata H, Takaoka M, Muraoka T, Fujisawa Y, et al. 2003. The role of renal sympathetic nervous system in the pathogenesis of ischemic acute renal failure. European Journal of Pharmacology 481:241−248

doi: 10.1016/j.ejphar.2003.09.036

[117]

Venkatachalam MA, Weinberg JM, Kriz W, Bidani AK. 2015. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. Journal of the American Society of Nephrology 26:1765−1776

doi: 10.1681/ASN.2015010006

[118]

Tan KS, Armugam A, Sepramaniam S, Lim KY, Setyowati KD, et al. 2009. Expression profile of microRNAs in young stroke patients. PLoS One 4:e7689

doi: 10.1371/journal.pone.0007689

[119]

Kato M, Arce L, Wang M, Putta S, Lanting L, et al. 2011. A microRNA circuit mediates transforming growth factor-β1 autoregulation in renal glomerular mesangial cells. Kidney International 80:358−368

doi: 10.1038/ki.2011.43

[120]

Long J, Wang Y, Wang W, Chang BH, Danesh FR. 2011. MicroRNA-29c is a signature microRNA under high glucose conditions that targets Sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy. The Journal of Biological Chemistry 286:11837−11848

doi: 10.1074/jbc.M110.194969

[121]

Zhong X, Chung AC, Chen HY, Meng XM, Lan HY. 2011. Smad3-mediated upregulation of miR-21 promotes renal fibrosis. Journal of the American Society of Nephrology 22:1668−1681

doi: 10.1681/ASN.2010111168

[122]

Hénaut L, Grissi M, Brazier F, Assem M, Poirot-Leclercq S, et al. 2019. Cellular and molecular mechanisms associated with ischemic stroke severity in female mice with chronic kidney disease. Scientific Reports 9:6432

doi: 10.1038/s41598-019-42933-0

[123]

Ajmo CT Jr, Collier LA, Leonardo CC, Hall AA, Green SM, et al. 2009. Blockade of adrenoreceptors inhibits the splenic response to stroke. Experimental Neurology 218:47−55

doi: 10.1016/j.expneurol.2009.03.044

[124]

Yan FL, Zhang JH. 2014. Role of the sympathetic nervous system and spleen in experimental stroke-induced immunodepression. Medical Science Monitor 20:2489−2496

doi: 10.12659/MSM.890844

[125]

Zou Y, Li S, Chen T, Li Z, Gao X, et al. 2022. Astragaloside IV ameliorates peripheral immunosuppression induced by cerebral ischemia through inhibiting HPA axis. International Immunopharmacology 105:108569

doi: 10.1016/j.intimp.2022.108569

[126]

Xu Y, Ge Y, Zhou M, Zhang Z. 2022. Clenbuterol, a selective β2-adrenergic receptor agonist, inhibits or limits post-stroke pneumonia, but increases infarct volume in MCAO mice. Journal of Inflammation Research 15:295−309

doi: 10.2147/JIR.S344521

[127]

Xiao W, Guo S, Chen L, Luo Y. 2019. The role of Interleukin-33 in the modulation of splenic T-cell immune responses after experimental ischemic stroke. Journal of Neuroimmunology 333:576970

doi: 10.1016/j.jneuroim.2019.576970

[128]

Yang H, Zhang A, Zhang Y, Ma S, Wang C. 2016. Resveratrol pretreatment protected against cerebral ischemia/reperfusion injury in rats via expansion of T regulatory cells. Journal of Stroke and Cerebrovascular Diseases 25:1914−1921

doi: 10.1016/j.jstrokecerebrovasdis.2016.04.014

[129]

Zhu W, Dotson AL, Libal NL, Lapato AS, Bodhankar S, et al. 2015. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice. Neuroscience 288:112−119

doi: 10.1016/j.neuroscience.2014.12.037

[130]

Dames C, Winek K, Beckers Y, Engel O, Meisel A, et al. 2018. Immunomodulatory treatment with systemic GM-CSF augments pulmonary immune responses and improves neurological outcome after experimental stroke. Journal of Neuroimmunology 321:144−149

doi: 10.1016/j.jneuroim.2018.03.005

[131]

McCulloch L, Harris AJ, Malbon A, Daniels MJD, Younas M, et al. 2022. Treatment with IgM-enriched intravenous immunoglobulins enhances clearance of stroke-associated bacterial lung infection. Immunology 167:558−575

doi: 10.1111/imm.13553

[132]

Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, et al. 2013. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke 44:3498−3508

doi: 10.1161/STROKEAHA.113.002470

[133]

Xie Z, Xin M, Yu F, Zhu X. 2024. Aprepitant alleviates poststroke pneumonia in a mouse model of middle cerebral artery occlusion. Rejuvenation Research 27:102−109

doi: 10.1089/rej.2024.0011

[134]

Conesa MPB, Blixt FW, Peesh P, Khan R, Korf J, et al. 2023. Stabilizing histamine release in gut mast cells mitigates peripheral and central inflammation after stroke. Journal of Neuroinflammation 20:230

doi: 10.1186/s12974-023-02887-7

[135]

He X, Cai Q, Li J, Guo W. 2018. Involvement of brain-gut axis in treatment of cerebral infarction by β-asaron and paeonol. Neuroscience Letters 666:78−84

doi: 10.1016/j.neulet.2017.12.036

[136]

Yuan Q, Xin L, Han S, Su Y, Wu R, et al. 2021. Lactulose improves neurological outcomes by repressing harmful bacteria and regulating inflammatory reactions in mice after stroke. Frontiers in Cellular and Infection Microbiology 11:644448

doi: 10.3389/fcimb.2021.644448

[137]

Dou Z, Rong X, Zhao E, Zhang L, Lv Y. 2019. Neuroprotection of resveratrol against focal cerebral ischemia/reperfusion injury in mice through a mechanism targeting gut-brain axis. Cellular and Molecular Neurobiology 39:883−898

doi: 10.1007/s10571-019-00687-3

[138]

Xie Y, Zou X, Han J, Zhang Z, Feng Z, et al. 2022. Indole-3-propionic acid alleviates ischemic brain injury in a mouse middle cerebral artery occlusion model. Experimental Neurology 353:114081

doi: 10.1016/j.expneurol.2022.114081

[139]

Liu C, Cheng X, Zhong S, Liu Z, Liu F, et al. 2022. Long-term modification of gut microbiota by broad-spectrum antibiotics improves stroke outcome in rats. Stroke and Vascular Neurology 7:381−389

doi: 10.1136/svn-2021-001231

[140]

Zhai Y, Luo Y, Mo X, Yang P, Pang Y, et al. 2023. Zhuang medicine Shuanglu Tongnao Compound Recipe treats stroke by affecting the intestinal flora regulated by the TLR4/NF-κB signaling pathway. Annals of Translational Medicine 11:174

doi: 10.21037/atm-23-253

[141]

Jin R, Zhu X, Liu L, Nanda A, Granger DN, et al. 2013. Simvastatin attenuates stroke-induced splenic atrophy and lung susceptibility to spontaneous bacterial infection in mice. Stroke 44:1135−1143

doi: 10.1161/STROKEAHA.111.000633

[142]

Su LJ, Ren YC, Chen Z, Ma HF, Zheng F, et al. 2022. Ginsenoside Rb1 improves brain, lung, and intestinal barrier damage in middle cerebral artery occlusion/reperfusion (MCAO/R) mice via the PPARγ signaling pathway. Chinese Journal of Natural Medicines 20:561−571

doi: 10.1016/S1875-5364(22)60204-8

[143]

Li M, Wang S, Zhang C, Chi C, Liu R, et al. 2023. Escin alleviates stress-induced intestinal dysfunction to protect brain injury by regulating the gut-brain axis in ischemic stroke rats. International Immunopharmacology 115:109659

doi: 10.1016/j.intimp.2022.109659

[144]

Lyu M, Cui Y, Zhao T, Ning Z, Ren J, et al. 2018. Tnfrsf12a-mediated atherosclerosis signaling and inflammatory response as a common protection mechanism of shuxuening injection against both myocardial and cerebral ischemia-reperfusion injuries. Frontiers in Pharmacology 9:312

doi: 10.3389/fphar.2018.00312

[145]

Wang R, Liu YY, Liu XY, Jia SW, Zhao J, et al. 2014. Resveratrol protects neurons and the myocardium by reducing oxidative stress and ameliorating mitochondria damage in a cerebral ischemia rat model. Cellular Physiology and Biochemistry 34:854−864

doi: 10.1159/000366304

[146]

Maysami S, Wong R, Pradillo JM, Denes A, Dhungana H, et al. 2016. A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. Journal of Cerebral Blood Flow and Metabolism 36(3):596−605

doi: 10.1177/0271678X15606714

[147]

Mergenthaler P, Meisel A. 2012. Do stroke models model stroke. Disease Models & Mechanisms 5:718−725

doi: 10.1242/dmm.010033

[148]

McCann SK, Lawrence CB. 2020. Comorbidity and age in the modelling of stroke: are we still failing to consider the characteristics of stroke patients? BMJ Open Science 4:e100013

doi: 10.1136/bmjos-2019-100013

[149]

Wen J, Zhou Q, Xu F, Yue J, Zhang Y, et al. 2025. Significance of the peripheral blood Treg/Th17 ratio as a prognostic immune biomarker in newly diagnosed multiple myeloma and its correlation with 1q21 gain/amplification. Frontiers in Immunology 16:1595613

doi: 10.3389/fimmu.2025.1595613

[150]

Yu W, Yin N, Yang Y, Xuan C, Liu X, et al. 2022. Rescuing ischemic stroke by biomimetic nanovesicles through accelerated thrombolysis and sequential ischemia-reperfusion protection. Acta Biomaterialia 140:625−640

doi: 10.1016/j.actbio.2021.12.009

[151]

Liu Z, Xia Q, Ma D, Wang Z, Li L, et al. 2023. Biomimetic nanoparticles in ischemic stroke therapy. Discover Nano 18:40

doi: 10.1186/s11671-023-03824-6

[152]

Zhang T, Ryu MS, Wu X, Yang HJ, Jeong SJ, et al. 2021. Alleviation of neuronal cell death and memory deficit with chungkookjang made with Bacillus amyloliquefaciens and Bacillus subtilis potentially through promoting gut-brain axis in artery-occluded gerbils. Foods (Basel, Switzerland) 10:2697

doi: 10.3390/foods10112697

[153]

Guo HH, Shen HR, Tang MZ, Sheng N, Ding X, et al. 2023. Microbiota-derived short-chain fatty acids mediate the effects of Dengzhan Shengmai in ameliorating cerebral ischemia via the gut-brain axis. Journal of Ethnopharmacology 306:116158

doi: 10.1016/j.jep.2023.116158

[154]

Wang K, Chen Y, Cao J, Liang R, Qiao Y, et al. 2022. Mechanism of Huangqi-Honghua combination regulating the gut microbiota to affect bile acid metabolism towards preventing cerebral ischaemia-reperfusion injury in rats. Pharmaceutical Biology 60:2189−2199

doi: 10.1080/13880209.2022.2136209

[155]

Zhang H, Hui X, Wang Y, Wang Y, Lu X. 2022. Angong Niuhuang Pill ameliorates cerebral ischemia/reperfusion injury in mice partly by restoring gut microbiota dysbiosis. Frontiers in Pharmacology 13:1001422

doi: 10.3389/fphar.2022.1001422

[156]

Sun H, Guo Y, Wang H, Yin A, Hu J, et al. 2022. Gut commensal Parabacteroides distasonis alleviates inflammatory arthritis. Gut 72:1664−1677

doi: 10.1136/gutjnl-2022-327756

[157]

Zhou W, Wu WH, Si ZL, Liu HL, Wang H, et al. 2022. The gut microbe Bacteroides fragilis ameliorates renal fibrosis in mice. Nature Communications 13:6081

doi: 10.1038/s41467-022-33824-6

[158]

Zhang Y, Xu D, Cai X, Xing X, Shao X, et al. 2025. Gut commensal Barnesiella intestinihominis ameliorates hyperglycemia and liver metabolic disorders. Advanced Science 12:e2411181

doi: 10.1002/advs.202411181

[159]

Lee J, d'Aigle J, Atadja L, Quaicoe V, Honarpisheh P, et al. 2020. Gut microbiota-derived short-chain fatty acids promote poststroke recovery in aged mice. Circulation Research 127:453−465

doi: 10.1161/CIRCRESAHA.119.316448

[160]

Sadler R, Cramer JV, Heindl S, Kostidis S, Betz D, et al. 2020. Short-chain fatty acids improve poststroke recovery via immunological mechanisms. The Journal of Neuroscience 40:1162−1173

doi: 10.1523/JNEUROSCI.1359-19.2019

[161]

Wang J, Zhong Y, Zhu H, Mahgoub OK, Jian Z, et al. 2022. Different gender-derived gut microbiota influence stroke outcomes by mitigating inflammation. Journal of Neuroinflammation 19:245

doi: 10.1186/s12974-022-02606-8

[162]

Zeng X, Li J, Shan W, Lai Z, Zuo Z. 2023. Gut microbiota of old mice worsens neurological outcome after brain ischemia via increased valeric acid and IL-17 in the blood. Microbiome 11:204

doi: 10.1186/s40168-023-01648-1

[163]

Cramer SC. 2018. Treatments to promote neural repair after stroke. Journal of Stroke 20:57−70

doi: 10.5853/jos.2017.02796

[164]

Stinear CM, Lang CE, Zeiler S, Byblow WD. 2020. Advances and challenges in stroke rehabilitation. The Lancet Neurology 19:348−360

doi: 10.1016/S1474-4422(19)30415-6

[165]

Lu XX, Hong ZQ, Tan Z, Sui MH, Zhuang ZQ, et al. 2017. Nicotinic acetylcholine receptor alpha7 subunit mediates vagus nerve stimulation-induced neuroprotection in acute permanent cerebral ischemia by a7nAchR/JAK2 pathway. Medical Science Monitor 23:6072−6081

doi: 10.12659/msm.907628

[166]

Arsava EM, Topcuoglu MA, Ay I, Ozdemir AO, Gungor IL, et al. 2022. Assessment of safety and feasibility of non-invasive vagus nerve stimulation for treatment of acute stroke. Brain Stimulation 15:1467−1474

doi: 10.1016/j.brs.2022.10.012

[167]

Zhao JJ, Wang ZH, Zhang YJ, Wang WJ, Cheng AF, et al. 2022. The mechanisms through which auricular vagus nerve stimulation protects against cerebral ischemia/reperfusion injury. Neural Regeneration Research 17:594−600

doi: 10.4103/1673-5374.320992

[168]

Du L, He X, Xiong X, Zhang X, Jian Z, et al. 2024. Vagus nerve stimulation in cerebral stroke: biological mechanisms, therapeutic modalities, clinical applications, and future directions. Neural Regeneration Research 19:1707−1717

doi: 10.4103/1673-5374.389365

[169]

Ay I, Napadow V, Ay H. 2015. Electrical stimulation of the vagus nerve dermatome in the external ear is protective in rat cerebral ischemia. Brain Stimulation 8:7−12

doi: 10.1016/j.brs.2014.09.009

[170]

Wu D, Ma J, Zhang L, Wang S, Tan B, et al. 2020. Effect and safety of transcutaneous auricular vagus nerve stimulation on recovery of upper limb motor function in subacute ischemic stroke patients: a randomized pilot study. Neural Plasticity 2020:8841752

[171]

Ahmed I, Mustafaoglu R, Rossi S, Cavdar FA, Agyenkwa SK, et al. 2023. Non-invasive brain stimulation techniques for the improvement of upper limb motor function and performance in activities of daily living after stroke: a systematic review and network meta-analysis. Archives of Physical Medicine and Rehabilitation 104:1683−1697

doi: 10.1016/j.apmr.2023.04.027

[172]

Qiao LY, Huang FJ, Zhao M, Xie JH, Shi J, et al. 2014. A two-year follow-up study of cotransplantation with neural stem/progenitor cells and mesenchymal stromal cells in ischemic stroke patients. Cell Transplantation 23:S65−S72

doi: 10.3727/096368914x684961

[173]

Moniche F, Gonzalez A, Gonzalez-Marcos JR, Carmona M, Piñero P, et al. 2012. Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43:2242−2244

doi: 10.1161/STROKEAHA.112.659409

[174]

Kawabori M, Kuroda S, Sugiyama T, Ito M, Shichinohe H, et al. 2012. Intracerebral, but not intravenous, transplantation of bone marrow stromal cells enhances functional recovery in rat cerebral infarct: an optical imaging study. Neuropathology 32:217−226

doi: 10.1111/j.1440-1789.2011.01260.x

[175]

Acosta SA, Tajiri N, Hoover J, Kaneko Y, Borlongan CV. 2015. Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke. Stroke 46:2616−2627

doi: 10.1161/STROKEAHA.115.009854

[176]

Keimpema E, Fokkens MR, Nagy Z, Agoston V, Luiten PG, et al. 2009. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathology and Applied Neurobiology 35:89−102

doi: 10.1111/j.1365-2990.2008.00961.x

[177]

Alrasheed AS, Aljahdali TA, Alghafli IA, Alghafli GA, Almuslim MF, et al. 2025. Safety and efficacy of stem cell therapy in ischemic stroke: a comprehensive systematic review and meta-analysis. Journal of Clinical Medicine 14:2118

doi: 10.3390/jcm14062118

[178]

Bang OY, Kim EH, Cha JM, Moon GJ. 2016. Adult stem cell therapy for stroke: challenges and progress. Journal of Stroke 18:256−266

doi: 10.5853/jos.2016.01263

[179]

Hyun I. 2010. The bioethics of stem cell research and therapy. The Journal of Clinical Investigation 120:71−75

doi: 10.1172/JCI40435

[180]

Zhan X, Dravid G, Ye Z, Hammond H, Shamblott M, et al. 2004. Functional antigen-presenting leucocytes derived from human embryonic stem cells in vitro. The Lancet 364:163−171

doi: 10.1016/S0140-6736(04)16629-4

[181]

Liu C, Yang J, Zhang C, Geng X, Zhao H. 2019. The changes of systemic immune responses during the neuroprotection induced by remote ischemic postconditioning against focal cerebral ischemia in mice. Neurological Research 41:26−36

doi: 10.1080/01616412.2018.1523037

[182]

Yang G, Yang Y, Li Y, Hu Z. 2020. Remote liver ischaemic preconditioning protects rat brain against cerebral ischaemia-reperfusion injury by activation of an AKT-dependent pathway. Experimental Physiology 105:852−863

doi: 10.1113/EP088394

[183]

Jiang G, Li X, Liu M, Li H, Shen H, et al. 2023. Remote ischemic postconditioning ameliorates stroke injury via the SDF-1α/CXCR4 signaling axis in rats. Brain Research Bulletin 197:31−41

doi: 10.1016/j.brainresbull.2023.03.011

[184]

Lv J, Guan W, You Q, Deng L, Zhu Y, et al. 2020. RIPC provides neuroprotection against ischemic stroke by suppressing apoptosis via the mitochondrial pathway. Scientific Reports 10:5361

doi: 10.1038/s41598-020-62336-w

[185]

Gao Y, Zhang TL, Zhang HJ, Gao J, Yang PF. 2024. A promising application of injectable hydrogels in nerve repair and regeneration for ischemic stroke. International Journal of Nanomedicine 19:327−345

doi: 10.2147/IJN.S442304

[186]

Lam J, Lowry WE, Carmichael ST, Segura T. 2014. Delivery of iPS-NPCs to the stroke cavity within a hyaluronic acid matrix promotes the differentiation of transplanted cells. Advanced Functional Materials 24:7053−7062

doi: 10.1002/adfm.201401483

[187]

Li B, Liu Y, Liu J, Sun H, Feng Y, et al. 2023. Cerebral multi-autoregulation model based enhanced external counterpulsation treatment planning for cerebral ischemic stroke. Journal of Cerebral Blood Flow and Metabolism 43:1764−1778

doi: 10.1177/0271678X231179542

[188]

Avey S, Chatterjee M, Manyakov NV, Cooper P, Sabins N, et al. 2024. Using a wearable patch to develop a digital monitoring biomarker of inflammation in response to LPS challenge. Clinical and Translational Science 17:e13734

doi: 10.1111/cts.13734

[189]

Lerman I, Bu Y, Singh R, Silverman HA, Bhardwaj A, et al. 2025. Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation. Bioelectronic Medicine 11:1

doi: 10.1186/s42234-024-00163-4

[190]

Ronaldson-Bouchard K, Teles D, Yeager K, Tavakol DN, Zhao Y, et al. 2022. A multi-organ chip with matured tissue niches linked by vascular flow. Nature Biomedical Engineering 6:351−371

doi: 10.1038/s41551-022-00882-6

[191]

Wevers NR, Nair AL, Fowke TM, Pontier M, Kasi DG, et al. 2021. Modeling ischemic stroke in a triculture neurovascular unit on-a-chip. Fluids and Barriers of the CNS 18:59

doi: 10.1186/s12987-021-00294-9

[192]

Kim S, Kim M, Grant GA, Lee W. 2024. The neurovascular unit-on-a-chip: modeling ischemic stroke to stem cell therapy. Neural Regeneration Research 19:1431−1432

doi: 10.4103/1673-5374.385296

[193]

Dawson J, Engineer ND, Prudente CN, Pierce D, Francisco G, et al. 2020. Vagus nerve stimulation paired with upper-limb rehabilitation after stroke: one-year follow-up. Neurorehabilitation and Neural Repair 34:609−615

doi: 10.1177/1545968320924361

[194]

Li JN, Xie CC, Li CQ, Zhang GF, Tang H, et al. 2022. Efficacy and safety of transcutaneous auricular vagus nerve stimulation combined with conventional rehabilitation training in acute stroke patients: a randomized controlled trial conducted for 1 year involving 60 patients. Neural Regeneration Research 17:1809−1813

doi: 10.4103/1673-5374.332155

[195]

Ackland GL, Crane D, Ahuja S, Patel A, Martin T, et al. 2025. Transauricular vagus nerve stimulation in acute ischaemic stroke requiring mechanical thrombectomy: sham-controlled, randomised device trial. Translational Stroke Research 17:10

doi: 10.1007/s12975-025-01404-7

[196]

Moniche F, Cabezas-Rodriguez JA, Valverde R, Escudero-Martinez I, Lebrato-Hernandez L, et al. 2023. Safety and efficacy of intra-arterial bone marrow mononuclear cell transplantation in patients with acute ischaemic stroke in Spain (IBIS trial): a phase 2, randomised, open-label, standard-of-care controlled, multicentre trial. The Lancet Neurology 22:137−146

doi: 10.1016/S1474-4422(22)00526-9

[197]

Bang OY, Lee JS, Lee PH, Lee G. 2005. Autologous mesenchymal stem cell transplantation in stroke patients. Annals of Neurology 57:874−882

doi: 10.1002/ana.20501

[198]

Jaillard A, Hommel M, Moisan A, Zeffiro TA, Favre-Wiki IM, et al. 2020. Autologous mesenchymal stem cells improve motor recovery in subacute ischemic stroke: a randomized clinical trial. Translational Stroke Research 11:910−923

doi: 10.1007/s12975-020-00787-z

[199]

Kalladka D, Sinden J, Pollock K, Haig C, McLean J, et al. 2016. Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study. The Lancet 388:787−796

doi: 10.1016/S0140-6736(16)30513-X

[200]

Chen HS, Cui Y, Li XQ, Wang XH, Ma YT, et al. 2022. Effect of remote ischemic conditioning vs usual care on neurologic function in patients with acute moderate ischemic stroke: the RICAMIS randomized clinical trial. Journal of the American Medical Association 328:627−636

doi: 10.1001/jama.2022.13123